These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35927744)

  • 1. Oxymetazoline hydrochloride ophthalmic solution, 0.1%, boosts the effects of botulinum toxin on blepharospasm: a case series.
    Sung J; Song A; Song M; Song J
    J Med Case Rep; 2022 Aug; 16(1):299. PubMed ID: 35927744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of nonsurgical facial rejuvenation and the role of oxymetazoline hydrochloride ophthalmic solution, 0.1% in periorbital revitalization.
    Goldberg DJ; Andriessen A; Gold M; Lolis MS; Marchbein S; Nestor MS; Ros A
    J Cosmet Dermatol; 2024 Apr; 23(4):1122-1130. PubMed ID: 38348575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired blepharoptosis secondary to essential blepharospasm.
    Bodker FS; Olson JJ; Putterman AM
    Ophthalmic Surg; 1993 Aug; 24(8):546-50. PubMed ID: 8233320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of Upper Blepharoptosis After Cosmetic Botulinum Toxin Type A.
    Steinsapir KD; Groth MJ; Boxrud CA
    Dermatol Surg; 2015 Jul; 41(7):833-40. PubMed ID: 26057409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polytetrafluoroethylene frontalis suspension in blepharospasm with eyelid apraxia: an effective and well-tolerated adjunct to botulinum toxin therapy.
    Sweeney AR; Dermarkarian CR; Williams KJ; Allen RC; Yen MT
    Orbit; 2021 Feb; 40(1):39-43. PubMed ID: 32172614
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of blepharospasm with medication, surgery and type A botulinum toxin.
    Arthurs B; Flanders M; Codère F; Gauthier S; Dresner S; Stone L
    Can J Ophthalmol; 1987 Feb; 22(1):24-8. PubMed ID: 3815152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Severe Botulinum-Induced Eyelid Ptosis With Pretarsal Botulinum Toxin and Oxymetazoline Hydrochloride 0.1.
    Bernardini FP; Skippen B; Croasdell B; Cerón Bohórquez JM; Murray G; Sayed K; Walker L; Hartstein ME;
    Aesthet Surg J; 2023 Aug; 43(9):955-961. PubMed ID: 36943792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the injection botulinum toxin A in cases of blepharospasm syndrome, hemifacial spasm and Meige's syndrome.
    Bastola P; Chaudhary M; Agrawal JP; Shah DN
    Kathmandu Univ Med J (KUMJ); 2010; 8(31):305-10. PubMed ID: 22610735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SURGICAL ASPECT OF BLEPHAROSPASM TREATMENT: A CASE REPORT.
    Dinjar K; Zubčić V; Kopić A; Kopić V; Popić B; Holik D
    Acta Clin Croat; 2020 Jun; 59(2):377-381. PubMed ID: 33456129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary on: Management of Severe Botulinum-Induced Eyelid Ptosis With Pretarsal Botulinum Toxin and Oxymetazoline Hydrochloride 0.1.
    Carruthers J
    Aesthet Surg J; 2023 Aug; 43(9):962-963. PubMed ID: 36978211
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of botulinum toxin in blepharospasm and other facial spasms.
    Ruusuvaara P; Setälä K
    Acta Ophthalmol (Copenh); 1987 Jun; 65(3):313-9. PubMed ID: 3618155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Cakmur R; Ozturk V; Uzunel F; Donmez B; Idiman F
    J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Repeated Eyelid Injections with Botulinum Toxin A on Innervation of Treated Muscles in Patients with Blepharospasm.
    Olson RM; Mokhtarzadeh A; McLoon LK; Harrison AR
    Curr Eye Res; 2019 Mar; 44(3):257-263. PubMed ID: 30380945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
    Bhidayasiri R; Cardoso F; Truong DD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin-induced blepharoptosis: Anatomy, etiology, prevention, and therapeutic options.
    Nestor MS; Han H; Gade A; Fischer D; Saban Y; Polselli R
    J Cosmet Dermatol; 2021 Oct; 20(10):3133-3146. PubMed ID: 34378298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myotomy In Situ for Essential Blepharospasm Refractory to Botulinum Toxin.
    Lai HT; Chen AD; Lee SS; Lin YH; Lai CS
    Ann Plast Surg; 2020 Jan; 84(1S Suppl 1):S74-S79. PubMed ID: 31833891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin treatment of blepharospasm.
    Elston JS
    Adv Neurol; 1988; 50():579-81. PubMed ID: 3400511
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination of blepharospasm and apraxia of eyelid opening: a condition resistant to treatment.
    Rana AQ; Shah R
    Acta Neurol Belg; 2012 Mar; 112(1):95-6. PubMed ID: 22427299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Myectomy and Myotomy In Situ for the Management of Refractory Blepharospasm in Meige Syndrome.
    Lai CS; Wang YC; Ramachandran S; Chang YP; Huang SH; Hsieh MW
    Ann Plast Surg; 2023 Apr; 90(1 Suppl 1):S84-S88. PubMed ID: 36752539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results and complications of botulinum A toxin in the treatment of blepharospasm.
    Dutton JJ; Buckley EG
    Ophthalmology; 1988 Nov; 95(11):1529-34. PubMed ID: 3211461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.